FYERS
Home
/
Stocks
/
Profit Loss
/
Fischer Medical Ventures Profit & Loss

Fischer Medical Ventures Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
₹82 Cr₹98 Cr₹101 Cr₹86 Cr₹23 Cr₹49 Cr₹12 Cr₹40 Cr₹10 Cr₹21 Cr
₹1 Cr₹1 Cr₹1 Cr₹2 Cr₹7 Cr₹15 L₹38 L₹22 L₹74 L₹47 L
₹83 Cr₹99 Cr₹102 Cr₹89 Cr₹31 Cr₹49 Cr₹12 Cr₹40 Cr₹11 Cr₹21 Cr
₹72 Cr₹98 Cr₹80 Cr₹71 Cr₹20 Cr₹47 Cr₹12 Cr₹39 Cr₹11 Cr₹18 Cr
₹13 Cr₹2 Cr₹23 Cr₹19 Cr₹12 Cr₹3 Cr₹88 L₹72 L₹48 L₹3 Cr
₹4 Cr₹4 Cr₹64 L₹92 L₹66 L₹23 L₹7 L₹5 L₹13 L₹5 L
₹8 Cr-₹2 Cr₹21 Cr₹17 Cr₹10 Cr₹2 Cr₹25 L₹38 L₹8 L₹3 Cr
₹4 Cr-₹7 Cr₹19 Cr₹14 Cr₹5 Cr₹1 Cr-₹17 L₹46 L-₹12 L₹3 Cr

Share Price Live Stats

Open (₹)35.95
Volume (₹)1.41 L
High (₹)35.98
Upper Circuit43.04
Low (₹)34.66
Lower Circuit28.70
Prev Close35.87
52W High (₹)124.70
Price34.66
52W Low (₹)31.05

Share Market Cap & Key Ratios Overview

M.Cap (₹)2513.87 Cr
Div. Yield (%)0.00
PE Ratio84.29
Debt to Equity0.20
Price to Book18.64
Book Value4.82
EPS (TTM)0.43
Face Value1.00
ROE (%)0.62

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
ADANIENTNSE
AEGISLOGNSE
CPPLUSNSE
PREMIERENENSE
REDINGTONNSE
HONASANSE
LLOYDSENTNSE
SGMARTNSE
MMTCNSE
ENTERONSE
FISCHERNSE
LTP
1W Low
1W High
Market cap (₹)
2982.4-94.8 (-3.08%)
2976.60
3083.70
4,13,847Cr
1340.5+32.9 (2.52%)
1287.70
1385
47,494Cr
3779.3-49.8 (-1.30%)
3755
3900
45,311Cr
954.5-13.4 (-1.38%)
950.10
980.50
44,240Cr
379.35-12.65 (-3.23%)
376
398.85
30,775Cr
467.7-7.95 (-1.67%)
467
478.15
15,354Cr
68.42-1.59 (-2.27%)
67.60
70.33
10,654Cr
732.3-34.25 (-4.47%)
730
775
9,468Cr
61.05-1.18 (-1.90%)
61.01
62.99
9,294Cr
1764.2-28.7 (-1.60%)
1730
1840.40
7,918Cr
34.66-0.24 (-0.69%)
33.68
36.14
2,514Cr

Key Highlights of Fischer Medical Ventures Ltd’s P&L

In 2025-03-31, Fischer Medical Ventures Ltd reported total revenue of ₹112.19Cr, compared with ₹21.48Cr in 2024-03-31, reflecting Fischer Medical Ventures Ltd turnover.

Depreciation was ₹1.63Cr and finance costs were ₹49.36Lakh in 2025-03-31

Profit Before Tax (PBT) has been ₹2.22Cr in 2025-03-31 as compared to ₹2.11Cr in 2024-03-31.

Net Profit (PAT) was ₹1.48Cr in 2025-03-31 compared with ₹1.38Cr in 2024-03-31.

Earnings per share (EPS) were ₹0.23 in 2025-03-31, compared with ₹0.26 in 2024-03-31.